SE9902918D0 - Methods for identification of compounds stimulating insulin secretion - Google Patents
Methods for identification of compounds stimulating insulin secretionInfo
- Publication number
- SE9902918D0 SE9902918D0 SE9902918A SE9902918A SE9902918D0 SE 9902918 D0 SE9902918 D0 SE 9902918D0 SE 9902918 A SE9902918 A SE 9902918A SE 9902918 A SE9902918 A SE 9902918A SE 9902918 D0 SE9902918 D0 SE 9902918D0
- Authority
- SE
- Sweden
- Prior art keywords
- identification
- compounds
- methods
- insulin secretion
- tubulin
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/62—Insulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
According to the invention beta -tubulin, as well as a 65 kDa polypeptide present in pancreatic beta -cells, have been identified as molecular targets for sulfonylurea compounds. These findings enable for the identification of new insulin secretagogues. The invention thus relates to the use of sulfonylurea compounds, such as e.g. glibenclamide, in methods for identification of compounds binding the 65 kDa polypeptide or tubulin, or stimulating tubulin polymerization and/or turnover, said compounds thereby stimulating insulin secretion.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902918A SE9902918D0 (en) | 1999-08-13 | 1999-08-13 | Methods for identification of compounds stimulating insulin secretion |
NZ516788A NZ516788A (en) | 1999-08-13 | 2000-08-10 | Methods for identification of compounds stimulating insulin secretion |
CA002380983A CA2380983A1 (en) | 1999-08-13 | 2000-08-10 | Methods for identification of compounds stimulating insulin secretion |
EP00953612A EP1200835A1 (en) | 1999-08-13 | 2000-08-10 | Methods for identification of compounds stimulating insulin secretion |
AU66032/00A AU6603200A (en) | 1999-08-13 | 2000-08-10 | Methods for identification of compounds stimulating insulin secretion |
JP2001517172A JP2003507365A (en) | 1999-08-13 | 2000-08-10 | Methods for identifying compounds that promote insulin secretion |
PCT/SE2000/001563 WO2001013121A1 (en) | 1999-08-13 | 2000-08-10 | Methods for identification of compounds stimulating insulin secretion |
US09/637,134 US6586188B1 (en) | 1999-08-13 | 2000-08-11 | Method for identification of compounds that bind to β-tubulin and stimulate insulin secretion |
NO20020576A NO20020576L (en) | 1999-08-13 | 2002-02-05 | Methods for identifying compounds that stimulate insulin secretion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902918A SE9902918D0 (en) | 1999-08-13 | 1999-08-13 | Methods for identification of compounds stimulating insulin secretion |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9902918D0 true SE9902918D0 (en) | 1999-08-13 |
Family
ID=20416679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9902918A SE9902918D0 (en) | 1999-08-13 | 1999-08-13 | Methods for identification of compounds stimulating insulin secretion |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1200835A1 (en) |
JP (1) | JP2003507365A (en) |
AU (1) | AU6603200A (en) |
CA (1) | CA2380983A1 (en) |
NO (1) | NO20020576L (en) |
NZ (1) | NZ516788A (en) |
SE (1) | SE9902918D0 (en) |
WO (1) | WO2001013121A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
WO1996011398A1 (en) * | 1994-10-07 | 1996-04-18 | Merck & Co., Inc. | Process for assessing tubulin protein polymerization |
GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
-
1999
- 1999-08-13 SE SE9902918A patent/SE9902918D0/en unknown
-
2000
- 2000-08-10 AU AU66032/00A patent/AU6603200A/en not_active Abandoned
- 2000-08-10 JP JP2001517172A patent/JP2003507365A/en active Pending
- 2000-08-10 EP EP00953612A patent/EP1200835A1/en not_active Withdrawn
- 2000-08-10 NZ NZ516788A patent/NZ516788A/en unknown
- 2000-08-10 WO PCT/SE2000/001563 patent/WO2001013121A1/en not_active Application Discontinuation
- 2000-08-10 CA CA002380983A patent/CA2380983A1/en not_active Abandoned
-
2002
- 2002-02-05 NO NO20020576A patent/NO20020576L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2003507365A (en) | 2003-02-25 |
NO20020576D0 (en) | 2002-02-05 |
CA2380983A1 (en) | 2001-02-22 |
AU6603200A (en) | 2001-03-13 |
WO2001013121A1 (en) | 2001-02-22 |
NO20020576L (en) | 2002-02-05 |
EP1200835A1 (en) | 2002-05-02 |
NZ516788A (en) | 2003-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1140840A4 (en) | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
ATE125867T1 (en) | FIBRONECTIN BINDING PROTEIN AND PRODUCTION THEREOF. | |
IL136690A0 (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
JO2373B1 (en) | W-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors | |
HK1155944A1 (en) | W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors | |
DE69823046D1 (en) | PRACTICAL IN VITRO SIALYLATION OF RECOMBINANT GLYC PROTEINS | |
HK1022701A1 (en) | Exendin analogues, processes for their preparationand medicaments containing them exendin. | |
WO2003008444A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
TR199700610A3 (en) | Low molecular weight soluble, tumor necrosis factor type-I and type-II proteins. | |
DE60125734D1 (en) | Neue aryl fructose-1,6-bisphosphatase inhibitoren | |
DE60025008D1 (en) | DETERMINATION OF ADRENOMEDULLIN-BINDING PROTEINS | |
ATE223481T1 (en) | PEPTIDE OF THE SOLUBLE FORM OF ACETYLCHOLINESTERASE WITH ACTIVITY AS A CALCIUM CHANNEL MODULATOR | |
ATE120494T1 (en) | FIBRONECTIN BINDING PROTEIN AND PRODUCTION THEREOF. | |
ATE139541T1 (en) | COLLAGEN-BINDING PROTEIN AND THE PRODUCTION THEREOF | |
SE9902918D0 (en) | Methods for identification of compounds stimulating insulin secretion | |
DE60036555D1 (en) | POLYPEPTIDE FRAGMENTS WITH A C-TERMINAL PART OF CATALASE FROM HELICOBACTER | |
WO2000032629A3 (en) | Antiviral peptides | |
ATE375390T1 (en) | G-PROTEIN-COUPLED RECEPTOR-LIKE PROTEINS | |
ATE393224T1 (en) | NUCLEIC ACID SEQUENCES OF HYPERPLASIA AND TUMORS OF THE THYROID | |
DE50006244D1 (en) | Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine | |
DK0938555T3 (en) | Structures and complexes of cyclin E | |
WO2003045325A3 (en) | Dopaminergic stimulatory factor | |
DK0925333T3 (en) | Antifreeze stabilization of aqueous coatings with antifreeze proteins | |
BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
GB0008504D0 (en) | Novel polypeptide |